Recombinant Plasma Protein Therapeutics Market - Market Share, Industry Analysis with Key Companies 2024-2031

Recombinant Plasma Protein Therapeutics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Type</li>
		<li>Snippet by Expression System</li>
		<li>Snippet by Application</li>
		<li>Snippet by Route of Administration</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising research and development activities and product approvals</li>
				<li>Rising prevalence of hematological conditions</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High cost of recombinant plasma protein therapeutics</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
		<li>PESTEL Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Attractiveness Index, By Type</li>
		</ol>
		</li>
		<li>Coagulation Factors*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Anticoagulants</li>
		<li>Immunoglobulins</li>
		<li>Albumin</li>
		<li>Colony Stimulating Factors</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Expression System</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System</li>
			<li>Market Attractiveness Index, By Expression System</li>
		</ol>
		</li>
		<li>Mammalian Cells*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Microorganisms</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Hemophilia*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Anemia</li>
		<li>Hypovolemia</li>
		<li>Hereditary Angioedema</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Route of Administration</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Subcutaneous*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Intra-Muscular</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>The U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country</li>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country</li>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country</li>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Takeda Pharmaceuticals
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>CSL</li>
		<li>Pfizer Inc.</li>
		<li>Novo Nordisk A/S.</li>
		<li>Pharming Healthcare, Inc.</li>
		<li>Amgen Inc.</li>
		<li>Sanofi</li>
		<li>Bayer AG</li>
		<li>Octapharma USA Inc.</li>
		<li>Janssen Global Services, LLC&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Recombinant Plasma Protein Therapeutics Market Value, By Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Recombinant Plasma Protein Therapeutics Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Recombinant Plasma Protein Therapeutics Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Recombinant Plasma Protein Therapeutics Market Value, By Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Recombinant Plasma Protein Therapeutics Market Value, By Type, 2022-2031 (US$ Million)

Table 8 Global Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2023, 2027 &amp; 2031 (US$ Million)

Table 9 Global Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2022-2031 (US$ Million)

Table 10 Global Recombinant Plasma Protein Therapeutics Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 11 Global Recombinant Plasma Protein Therapeutics Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2023, 2027 &amp; 2031 (US$ Million)

Table 13 Global Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 14 Global Recombinant Plasma Protein Therapeutics Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 15 Global Recombinant Plasma Protein Therapeutics Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Recombinant Plasma Protein Therapeutics Market Value, By Type, 2022-2031 (US$ Million)

Table 17 North America Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2022-2031 (US$ Million)

Table 18 North America Recombinant Plasma Protein Therapeutics Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 20 North America Recombinant Plasma Protein Therapeutics Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Recombinant Plasma Protein Therapeutics Market Value, By Type, 2022-2031 (US$ Million)

Table 22 South America Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2022-2031 (US$ Million)

Table 23 South America Recombinant Plasma Protein Therapeutics Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 25 South America Recombinant Plasma Protein Therapeutics Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Recombinant Plasma Protein Therapeutics Market Value, By Type, 2022-2031 (US$ Million)

Table 27 Europe Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2022-2031 (US$ Million)

Table 28 Europe Recombinant Plasma Protein Therapeutics Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 30 Europe Recombinant Plasma Protein Therapeutics Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Value, By Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Value, By Type, 2022-2031 (US$ Million)

Table 37 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Value, By Expression System, 2022-2031 (US$ Million)

Table 38 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 40 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Value, By Country, 2022-2031 (US$ Million)

Table 41 Takeda Pharmaceuticals: Overview

Table 42 Takeda Pharmaceuticals: Product Portfolio

Table 43 Takeda Pharmaceuticals: Key Developments

Table 44 CSL: Overview

Table 45 CSL: Product Portfolio

Table 46 CSL: Key Developments

Table 47 Pfizer Inc.: Overview

Table 48 Pfizer Inc.: Product Portfolio

Table 49 Pfizer Inc.: Key Developments

Table 50 Novo Nordisk A/S.: Overview

Table 51 Novo Nordisk A/S.: Product Portfolio

Table 52 Novo Nordisk A/S.: Key Developments

Table 53 Pharming Healthcare, Inc.: Overview

Table 54 Pharming Healthcare, Inc.: Product Portfolio

Table 55 Pharming Healthcare, Inc.: Key Developments

Table 56 Amgen Inc.: Overview

Table 57 Amgen Inc.: Product Portfolio

Table 58 Amgen Inc.: Key Developments

Table 59 Sanofi: Overview

Table 60 Sanofi: Product Portfolio

Table 61 Sanofi: Key Developments

Table 62 Bayer AG: Overview

Table 63 Bayer AG: Product Portfolio

Table 64 Bayer AG: Key Developments

Table 65 Octapharma USA Inc.: Overview

Table 66 Octapharma USA Inc.: Product Portfolio

Table 67 Octapharma USA Inc.: Key Developments

Table 68 Janssen Global Services, LLC: Overview

Table 69 Janssen Global Services, LLC: Product Portfolio

Table 70 Janssen Global Services, LLC: Key Developments

List of Figures

Figure 1 Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 2 Global Recombinant Plasma Protein Therapeutics Market Share, By Type, 2023 &amp; 2031 (%)

Figure 3 Global Recombinant Plasma Protein Therapeutics Market Share, By Expression System, 2023 &amp; 2031 (%)

Figure 4 Global Recombinant Plasma Protein Therapeutics Market Share, By Application, 2023 &amp; 2031 (%)

Figure 5 Global Recombinant Plasma Protein Therapeutics Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 6 Global Recombinant Plasma Protein Therapeutics Market Share, By Region, 2023 &amp; 2031 (%)

Figure 7 Global Recombinant Plasma Protein Therapeutics Market Y-o-Y Growth, By Type, 2023-2031 (%)

Figure 8 Coagulation Factors Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 9 Anticoagulants Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 10 Immunoglobulins Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 11 Albumin Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 12 Colony Stimulating Factors Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 13 Others Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 14 Global Recombinant Plasma Protein Therapeutics Market Y-o-Y Growth, By Expression System, 2023-2031 (%)

Figure 15 Mammalian Cells Expression System in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 16 Microorganisms Expression System in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 17 Global Recombinant Plasma Protein Therapeutics Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 18 Hemophilia Application in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 19 Anemia Application in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 20 Hypovolemia Application in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 21 Hereditary Angioedema Application in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 22 Others Application in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 23 Global Recombinant Plasma Protein Therapeutics Market Y-o-Y Growth, By Route of Administration, 2023-2031 (%)

Figure 24 Subcutaneous Route of Administration in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 25 Intra-Muscular Route of Administration in Global Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 26 Global Recombinant Plasma Protein Therapeutics Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 27 North America Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 28 North America Recombinant Plasma Protein Therapeutics Market Share, By Type, 2023 &amp; 2031 (%)

Figure 29 North America Recombinant Plasma Protein Therapeutics Market Share, By Expression System, 2023 &amp; 2031 (%)

Figure 30 North America Recombinant Plasma Protein Therapeutics Market Share, By Application, 2023 &amp; 2031 (%)

Figure 31 North America Recombinant Plasma Protein Therapeutics Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 32 North America Recombinant Plasma Protein Therapeutics Market Share, By Country, 2023 &amp; 2031 (%)

Figure 33 South America Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 34 South America Recombinant Plasma Protein Therapeutics Market Share, By Type, 2023 &amp; 2031 (%)

Figure 35 South America Recombinant Plasma Protein Therapeutics Market Share, By Expression System, 2023 &amp; 2031 (%)

Figure 36 South America Recombinant Plasma Protein Therapeutics Market Share, By Application, 2023 &amp; 2031 (%)

Figure 37 South America Recombinant Plasma Protein Therapeutics Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 38 South America Recombinant Plasma Protein Therapeutics Market Share, By Country, 2023 &amp; 2031 (%)

Figure 39 Europe Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 40 Europe Recombinant Plasma Protein Therapeutics Market Share, By Type, 2023 &amp; 2031 (%)

Figure 41 Europe Recombinant Plasma Protein Therapeutics Market Share, By Expression System, 2023 &amp; 2031 (%)

Figure 42 Europe Recombinant Plasma Protein Therapeutics Market Share, By Application, 2023 &amp; 2031 (%)

Figure 43 Europe Recombinant Plasma Protein Therapeutics Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 44 Europe Recombinant Plasma Protein Therapeutics Market Share, By Country, 2023 &amp; 2031 (%)

Figure 45 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 46 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Share, By Type, 2023 &amp; 2031 (%)

Figure 47 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Share, By Expression System, 2023 &amp; 2031 (%)

Figure 48 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Share, By Application, 2023 &amp; 2031 (%)

Figure 49 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 50 Asia-Pacific Recombinant Plasma Protein Therapeutics Market Share, By Country, 2023 &amp; 2031 (%)

Figure 51 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Value, 2022-2031 (US$ Million)

Figure 52 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Share, By Type, 2023 &amp; 2031 (%)

Figure 53 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Share, By Expression System, 2023 &amp; 2031 (%)

Figure 54 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Share, By Application, 2023 &amp; 2031 (%)

Figure 55 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 56 Takeda Pharmaceuticals: Financials

Figure 57 CSL: Financials

Figure 58 Pfizer Inc.: Financials

Figure 59 Novo Nordisk A/S.: Financials

Figure 60 Pharming Healthcare, Inc.: Financials

Figure 61 Amgen Inc.: Financials

Figure 62 Sanofi: Financials

Figure 63 Bayer AG: Financials

Figure 64 Octapharma USA Inc.: Financials

Figure 65 Janssen Global Services, LLC: Financials

Recombinant Plasma Protein Therapeutics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Plasma Protease C1-Inhibitor Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 24

Starting from

Blood Plasma Derivatives Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 31

Starting from

Therapeutic Plasma Exchange Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 03

Starting from